- Report
- March 2025
- 50 Pages
Global
From €2529EUR$2,650USD£2,119GBP
- Report
- March 2025
- 50 Pages
Global
From €2529EUR$2,650USD£2,119GBP
- Report
- March 2025
- 50 Pages
Global
From €2529EUR$2,650USD£2,119GBP
- Report
- March 2025
- 45 Pages
Europe
From €1813EUR$1,900USD£1,519GBP
- Report
- March 2023
- 132 Pages
Global
From €907EUR$950USD£760GBP
- Report
- March 2023
- 132 Pages
Global
From €907EUR$950USD£760GBP
- Book
- August 2012
- 748 Pages
- Report
- October 2023
- 497 Pages
Global
From €3407EUR$3,570USD£2,855GBP
- Book
- April 2019
- 288 Pages
- Book
- November 2011
- 224 Pages
Sulfonamide is a type of antibiotic used to treat bacterial infections. It works by inhibiting the growth of bacteria, preventing them from reproducing and spreading. Sulfonamide is used to treat a wide range of bacterial infections, including urinary tract infections, skin infections, and respiratory infections. It is also used to prevent certain types of malaria. Sulfonamide is available in both oral and intravenous forms, and is often used in combination with other antibiotics.
Sulfonamide is a widely used antibiotic, and is often prescribed as a first-line treatment for bacterial infections. It is generally well-tolerated, with few side effects. However, it is not effective against all types of bacteria, and some bacteria have developed resistance to it.
Some companies in the Sulfonamide market include Pfizer, Merck, GlaxoSmithKline, Sanofi, and Novartis. Show Less Read more